Disease or syndrome | Incidence | Carrier frequency | Percent of carriers with recessive mutations detected by the test | Carrier screening recommended by ACOG | Carrier screening recommended by ACMG | Screening panel used by author, Dr. Roman |
Cystic fibrosis | 1/2500 to 1/3300 | 1/19 to 1/29 | 97 | x | x | x |
Familial dysautonomia | 1/3600 to 1/5000 | 1/30 to 1/32 | 99 | x | x | x |
Canavan | 1/3000 to 1/6000 | 1/40 | 98 | x | x | x |
Tay-Sachs | 1/3000 to 1/3600 | 1/25 to 1/30 | 96 by enzyme, 94 by DNA | x | x | x |
Gaucher | 1/900 | 1/15 | 95 | x | x | x |
Mucolipidosis type IV | 1/40,000 to 1/62,500 | 1/100 to 1/127 | 95 | x | x | x |
Niemann-Pick SMPD-1 related (type A and B) | 1/32,000 | 1/90 | 95 | x | x | x |
Fanconi anemia group C | 1/32,000 | 1/89 | 99 | x | x | x |
Bloom | 1/40,000 to 1/48,000 | 1/100 | 95 to 97 | x | x | x |
Lipoamide dehydrogenase deficiency | 1/46,000 | 1/107 | >95 | x | ||
ABCC8-related familial hyperinsulinism | 1/18,000 | 1/68 | 90 | x | x | |
NEB-related nemaline myopathy type 2 | 1/113,000 | 1/120 | >95 | x | ||
Joubert | 1/34,000 | 1/102 | >99 | x | x | |
Usher type 1F | 1/86,000 | 1/165 | >75 | x | x | |
Usher type 3 | 1/57,000 | 1/107 | >95 | x | x | |
Glycogen storage type I | 1/16,000 | 1/64 | 98 | x | x | |
Maple syrup urine | 1/50,000 | 1/81 | >99 | x | x | |
Walker-Warburg | 1/60,500 | 1/149 | >95 | x |
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟